Cochrane · systematic review · CD011647
Interventions for hereditary haemochromatosis
Buzzetti, E, Kalafateli, M, Thorburn, D, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
Hepato-BiliaryAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
5
current version
GRADE rated
3
No studies
1
Included studies
NR
No studies 1 · 20%Ungraded 1 · 20%Very low 3 · 60%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Erythrocytapheresis versus phlebotomy for hereditary haemochromatosis
Population: people with hereditary haemochromatosis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Long‐term mortality Erythrocytapheresis vs phlebotomy | no estimate extracted | 1 participants | Ungraded |
Mortality Erythrocytapheresis vs phlebotomy | no estimate extracted | 1 study · 38 participants | Very low Downgraded: risk of bias, imprecision |
Serious adverse events Erythrocytapheresis vs phlebotomy | no estimate extracted | 1 study · 38 participants | Very low Downgraded: risk of bias, imprecision |
Health‐related quality of life EQ‐VAS. Scale from: 0 to 100. Erythrocytapheresis vs phlebotomy | no estimate extracted | 1 study · 38 participants | Very low Downgraded: risk of bias, imprecision |
Health‐related quality of life beyond one year Erythrocytapheresis vs phlebotomy | no estimate extracted | NR | No studies |